Unresectable Locally Advanced Or Metastatic Cancer clinical trials

Explore recruiting unresectable locally advanced or metastatic cancer clinical trials.

Recruiting unresectable locally advanced or metastatic cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Unresectable Locally Advanced Or Metastatic Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of TAK-280 in Patients With Unresectable Locally Advanced or Metastatic Cancer

Spain, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients with Unresectable Locally Advanced or Metastatic Cancer

Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unresectable Locally Advanced or Metastatic Cancer

Belgium, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Unresectable Locally Advanced Or Metastatic Cancer trials by city

Unresectable Locally Advanced Or Metastatic Cancer in Toronto Unresectable Locally Advanced Or Metastatic Cancer in Vancouver Unresectable Locally Advanced Or Metastatic Cancer in Montreal Unresectable Locally Advanced Or Metastatic Cancer in Calgary Unresectable Locally Advanced Or Metastatic Cancer in Edmonton Unresectable Locally Advanced Or Metastatic Cancer in Ottawa Unresectable Locally Advanced Or Metastatic Cancer in Winnipeg Unresectable Locally Advanced Or Metastatic Cancer in Quebec City Unresectable Locally Advanced Or Metastatic Cancer in Hamilton Unresectable Locally Advanced Or Metastatic Cancer in Kitchener Unresectable Locally Advanced Or Metastatic Cancer in London Unresectable Locally Advanced Or Metastatic Cancer in Halifax Unresectable Locally Advanced Or Metastatic Cancer in New York Unresectable Locally Advanced Or Metastatic Cancer in Los Angeles Unresectable Locally Advanced Or Metastatic Cancer in Chicago Unresectable Locally Advanced Or Metastatic Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease